Winton Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-23,762
Closed -$836K 1386
2025
Q4
$836K Sell
23,762
-44,938
-65% -$1.59M 0.03% 522
2025
Q3
$1.81M Buy
+68,700
New +$2.05M 0.07% 283
2021
Q4
Sell
-38,927
Closed -$244K 1415
2021
Q3
$244K Sell
38,927
-23,911
-38% -$148K 0.01% 1178
2021
Q2
$376K Sell
62,838
-5,328
-8% -$31.6K 0.02% 1070
2021
Q1
$431K Sell
68,166
-15,555
-19% -$109K 0.02% 964
2020
Q4
$471K Sell
83,721
-155,141
-65% -$940K 0.03% 821
2020
Q3
$1.39M Sell
238,862
-119,239
-33% -$821K 0.05% 677
2020
Q2
$2.58M Buy
358,101
+90,175
+34% +$599K 0.07% 521
2020
Q1
$1.25M Sell
267,926
-125,749
-32% -$773K 0.03% 711
2019
Q4
$3.16M Buy
+393,675
New +$2.87M 0.04% 628
2019
Q2
Sell
-21,122
Closed -$210K 1291
2019
Q1
$210K Buy
+21,122
New +$177K ﹤0.01% 949

Other funds holding VKTX